Commentary
Podcast
Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC
In Partnership With:
Dr Halmos discusses common AEs associated with the ADCs that are used in NSCLC and ways to manage and mitigate these toxicities.
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.
OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, supported by AstraZeneca, we had the pleasure of speaking with Balazs Halmos, MD, MS, about adverse effect (AE) management with antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC). Dr Halmos is a professor in the Departments of Oncology and Medicine at the Albert Einstein College of Medicine, as well as associate director of Clinical Science at Montefiore Einstein Comprehensive Cancer Center in Bronx, New York.
In our exclusive interview, Dr Halmos discussed common AEs that are associated with the ADCs that are used in NSCLC; the safety profile of datopotamab deruxtecan, as seen in the phase 3 TROPION-Lung01 trial (NCT04656652) in patients with advanced or metastatic NSCLC; and ways to manage and mitigate these toxicities.
___
That’s all we have for today! Thank you for listening to this episode of OncLive On Air, supported by AstraZeneca. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive is also on social media. On X, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air.
*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.
